U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07261306) titled 'Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis' on July 23.
Brief Summary: Psoriasis is a chronic inflammatory dermatoses which include well demarcated scaly erythematous plaques on whole body including scalp role of methotrexate vs tofacitinib is compared in this study
Study Start Date: Aug. 29
Study Type: INTERVENTIONAL
Condition:
Psoriasis
Intervention:
DRUG: Methotrexate
Methotrexate is an antifolate drug work by inhibiting enzyme dihydrofolate reductase and inhibit cell proliferation and play a role in psoriasis treatment
DRUG: Tofacitinib
Tofacitinib is janus kinase inhibitor and have ...